Q2 2022 DiaSorin SpA Earnings Call Transcript
Good afternoon. This is the Chorus Call conference operator. Welcome and thank you for joining the DiaSorin First Half 2022 Results Conference Call. (Operator Instructions)
At this time, I would like to turn the conference over to Mr. Carlo Rosa, CEO of DiaSorin. Please go ahead, sir.
Thank you operator. Ladies and gentlemen, good morning, and welcome to the H1 conference call. I'm going to make the initial remarks on the top line by geography and by technology and then I'm going to make a few comments on some of the major events that happened in the quarter, and then I'm going to leave to our CFO for the commentary on the numbers.
So starting from the technology. I will discuss immuno, I will discuss molecular, I will talk about license technology, and this last but not least, I will talk about COVID.
When it comes to immuno, which I remind everybody it includes our CLIA reagents as well our residual ELISA business franchise in H1 this plus 5% which is in line with our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
